Skip to main content

Table 1 Clinical data of patients

From: Batch correction of microarray data substantially improves the identification of genes differentially expressed in Rheumatoid Arthritis and Osteoarthritis

Sample name

Gender/ Age

Disease duration

RF

ESR (mm/h)

CRP (mg/ml)

ARA criteria

Concurrent medication

Rheumatoid Arthritis

       

EB87

F/65

12

+

50,00

106,7

5

NSAIDs

EB88

F/62

10

+

90,00

169,5

6

NSAIDs

EB213

F/69

15

+

94,00

99,1

4

NSAIDs, Leflunomide, Prednis

EB220

F/57

20

+

23,00

2,3

4

NSAID, MTX, Prednis.

EB221

F/66

12

+

7,00

5,4

4

Lantarel, MTX

EB227

F/49

25

+

12,00

2,4

5

NSAIDs, MTX, Prednis.

Osteoarthritis

       

EB168

F/68

20

-

18,00

20,3

0

NSAIDs

EB173

F/81

2,5

-

38,00

32,0

2

NSAIDs, Prednis.

EB190

M/56

5

-

6,00

0,5

1

NSAIDs

EB194

F/79

8

-

28,00

0,3

1

NSAIDs

EB202

M/65

5

-

7,00

3,0

0

NSAIDs

EB205

F/55

3

-

47,00

36,0

0

NSAIDs

  1. ARA, American Rheumatism Association (now American College of Rheumatology); CRP, C-reactive protein (normal range <5 mg/l); ESR, erythrocyte sedimentation rate; F, female; M, male; MTX, methotrexate; NSAIDs, non steroidal anti-inflammatory drugs; RF, rheumatoid factor;-,negative; +, positive.